BUENOS AIRES, January 20. /TASS/. Argentina’s National Administration of Drugs, Foods and Medical Devices (ANMAT) has approved the use of Russia’s Sputnik V vaccine against coronavirus for vaccination of people over 60 years old.
This is stated in the report of the department, which was published on Wednesday.
"After analyzing the new information provided for the VacunaGam-COVID-Vac (Sputnik V) vaccine, it was established, through the expansion report, that it is within an acceptable margin of safety, immunogenicity and efficacy for the age group over 60 years," according to the document.
"Taking into account that the safety, immunogenicity and efficacy parameters are acceptable for those over 60 years of age, this National Administration recommended to the Ministry of Health of the Nation the use of the Vaccine Gam-COVID-Vac in the mentioned age group," the regulator said.
Sputnik V became the first coronavirus vaccine to arrive in Argentina. The Russian Direct Investment Fund and the government of the country signed a contract for the supply of 10 million doses of the drug. The first batch of 300,000 doses of the first component was delivered to the South American republic on December 24. A day earlier, the country’s government issued a permit for the emergency use of the drug, but only for persons younger than 60. On December 29, Argentina started vaccination of health workers with Sputnik V.